Results 11 to 20 of about 59,250 (306)
Progress on Targeted Therapy of Radioiodine-refractory Differentiated Thyroid Cancer
Zhongliu Fangzhi Yanjiu, 2023 Targeted therapy has brought revolutionary breakthroughs for radioiodine-refractory differentiated thyroid cancer. New targeted drugs have prolonged the survival of patients with advanced differentiated thyroid cancer. Multiple tyrosine kinase inhibitors,
TENG Lisong, XU Zehang, WANG Weibin
doaj +2 more sources
Frontiers in Oncology, 2022 Hashimoto’s thyroiditis is the most common cause of hypothyroidism in the iodine-sufficient areas of the world. Differentiated thyroid cancer is the most common thyroid cancer subtype, accounting for more than 95% of cases, and it is considered a tumor ...
Federico Cappellacci +6 more
doaj +3 more sources
Differentiated Thyroid Cancer in Asians [PDF]
Endocrinology and Metabolism, 2016 In the past two decades, thyroid cancer has rapidly increased around the world, including in Korea [1]. Although the exact cause of this increase is still under debate, cancer screening with high-resolution ultrasound (US) might have led to earlier diagnosis of smaller thyroid cancers [2,3,4].
Bo Hyun Kim
doaj +3 more sources
Advancements in the treatment of differentiated thyroid cancer [PDF]
Therapeutic Advances in Endocrinology and Metabolism, 2021 Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the majority of thyroid malignancies. The threefold increase in DTC incidence over the last three decades has been largely attributed to advancements in detection of papillary thyroid microcarcinomas.
Latoya A Stewart, Jennifer H Kuo
exaly +4 more sources
Thyroid differentiation profile for differentiated thyroid cancer
Endocrine OncologyRadioactive iodine (RAI) treatment is an established therapeutic tool for ‘differentiated thyroid cancers’. The therapeutic effectiveness is linked to the preservation of the iodine-concentrating ability of the neoplastic tissue, a unique, inherent ...
Anthony J McGoron +3 more
doaj +3 more sources
Brazilian Journal of OncologyIntroduction: Pan-TRK immunohistochemistry staining can assess the protein expression from NTRK gene fusions. A little is known about its utility in differentiated thyroid cancer samples from children, adolescents, and young adults patients.
Ana Clara Oliveira Tosta Telles +11 more
doaj +2 more sources
Poorly Differentiated Cancer Thyroid, An overview [PDF]
Minia Journal of Medical Research, 2021 Worldwide, the incidence of thyroid cancer has greatly increased in the last decades with female predominance. Increase in incidence of more advanced disease has also been reported.
Mai Khalifa, Asmaa Fathy
doaj +1 more source
Review Article in Poorly Differentiated Cancer Thyroid, An overview. [PDF]
Minia Journal of Medical Research, 2020 Worldwide, the incidence of thyroid cancer has greatly increased in the last decades with female predominance. Increase in incidence of more advanced disease has also been reported.
Mai Khalifa, Asmaa Fathy
doaj +1 more source
Radionuclide monitoring of targeted therapy of iodine-negative differentiated thyroid cancer
Український радіологічний та онкологічний журнал, 2021 Background. Current management of treating iodine-negative metastases of differentiated thyroid cancer has its features. In recent years, tyrosine kinase inhibitors (sorafenib, sunitinib) have been registered and indicated to treat refractory forms of ...
О. І. Солодянникова +3 more
doaj +1 more source
Well Differentiated Thyroid Cancer [PDF]
Scandinavian Journal of Surgery, 2004 Differentiated thyroid cancer (DTC) accounts for 98 % of thyroid cancer, with neoplasms arising from the follicular cells (papillary, follicular and Hurthle cell thyroid cancer) and parafollicular cells (medullary thyroid cancer). This paper will focus on the well-differentiated thyroid cancers arising from the follicular epithelial cells. By retaining
N R, Caron, O H, Clark
openaire +4 more sources